Rhythm Pharmaceuticals, Inc.
NasdaqGM-RYTM
Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
Dec '23
LTM
| Trailing Valuation | LTM |
|---|---|
Stock Price | 106.3 |
Total Shares Outstanding | 66.7 |
Market Cap | 7,092 |
Total Enterprise Value (TEV) | 6,973.9 |
Buyback Yield | -0.2% |
Debt Paydown Yield | 0.3% |
Shareholder Yield | 0% |
P/S | 40.7 |
P/Gross Profit | 45.5 |
P/E | -34.3 |
Earnings Yield | -2.9% |
P/OCF | -65 |
P/FCF | -65 |
FCF Yield | -1.5% |
P/B | 47.7 |
EV/Sales | 40 |
EV/Gross Profit | 44.7 |
EV/EBITDA | -37.7 |
EV/EBIT | -37.5 |
EV/OCF | -63.9 |
EV/FCF | -63.9 |